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ABSTRACT
Objective: Obstructive sleep apnoea (OSA) is the most common sleep disorder and its prevalence 
has increased with the obesity pandemic. We aimed to explore the presence of  OSA in severe 
obesity and to evaluate the association of  body mass index (BMI) with sleep architecture, 
cognition, emotional distress and comorbidities in OSA versus non-OSA patients. Methods: A 
sample of  61 patients performed a neuropsychological battery that included tasks of  attention, 
memory, perceptual/visuospatial ability, vocabulary, inhibition, cognitive flexibility and distress 
symptomatology, before overnight polysomnography. Results: More than half  of  the sample had 
OSA. Excessive daytime sleepiness was not a prominent complaint. Sleep architecture was worse 
in the OSA than in the non-OSA group, and hypertension was increased with OSA, especially in 
the severe OSA group. A higher BMI was associated with cognitive distress and sleep variables and 
with type 2 diabetes. The apnoea-hypopnoea index (AHI) was correlated with gender and cognitive 
measurements. Cognitive complaints were associated with enhanced distress in both OSA and non-
OSA patients. Discussion: OSA is considerably present in severely obese patients. The BMI was 
strongly associated with other important anthropometric measurements along with worsening sleep 
architecture and lower executive functioning, both of  which may contribute to weight gain. The 
AHI was significantly higher in men and affected memory and maintaining sets on the Wisconsin 
Card Sorting Test which may represent a barrier to treatment adherence for this disorder. The 
substantial presence of  cognitive complaints in OSA and non-OSA patients suggests the need for 
psychological intervention focused on adaptive coping strategies, mostly for depressive symptoms. 
Given the current obesity epidemic, these results support the need for routine sleep investigation 
in obese people, particularly in primary care settings. BMI, neuropsychological and emotional 
screening can provide crucial information about asymptomatic and high-risk patients who require 
prompt sleep intervention and obesity treatment.
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INTRODUCTION
Obstructive sleep apnoea (OSA) is the most common 
sleep disorder. It is a chronic condition that has increased 
in prevalence over the past two decades. Its prevalence 
varies according to gender and age, and it is nearly twice 
as common in the obese population as in adults of  normal 
weight1. OSA has a large economic impact, affects quality of  
life and is associated with work-related injuries. It is a major 
public health issue that is exponentially increasing owing to 
the increased prevalence of  type 2 diabetes mellitus (DM) 
and obesity, ageing, and improvements in screening and 
testing methods2.
OSA is estimated to affect approximately 9% to 38% 
of  the general population based on an apnoea-hypopnoea index 
(AHI) of  ≥5 events/hour. It is more frequent in males and with 
advancing age3.
The condition is characterized by recurrent obstruction 
of  the upper airway during sleep due to mechanical dysfunction 
of  the throat’s musculature, resulting in a periodic cessation 
(apnoea) or reduction (hypopnoea) in breathing, with 
subsequent cyclic desaturations of  arterial blood4. Consequences 
are impaired blood oxygenation, repetitive hypoxia, sympathetic 
nervous system activation, increased blood pressure, sleep 
fragmentation and excessive daytime sleepiness (EDS)5. It has a 
negative impact on the cardiovascular and metabolic systems and 
is highly associated with hypertension (HTN), DM and stroke2. 
Repetitive hypoxia has been considered a major contributor 
to cerebrovascular changes such as structural and functional 
deterioration that lead to cognitive deficits, particularly in 
attention, memory and executive functioning6.
OSA also affects mental health, with increased clinical 
levels of  depressive symptoms, anxiety, irritability, fatigue or 
diminished energy resulting from the sleep deprivation and 
social effects of  the illness7. Depression and anxiety symptoms, 
reduced activity levels, medication and increased appetite may 
contribute to weight gain, worsening OSA.
Considering the prevalence of  obesity in patients with 
OSA, sufficient weight loss can confer benefits and significantly 
mitigate symptoms1,8. In fact, nighttime symptoms (snoring, 
gasping, insomnia or frequent arousals from sleep and morning 
headaches) and daytime symptoms (sleepiness, fatigue, poor 
concentration, irritability, depression, weight gain and decreased 
libido) should be confirmed by the medical evaluation and 
can be strengthened by the use of  screening questionnaires 
and anthropometric measurements. Questionnaires and 
anthropometric measurements play an essential role in OSA 
recognition and should also be applied in primary care settings, 
focusing on asymptomatic patients and high-risk groups such as 
obese people9,10.
Body mass index (BMI) is the most common 
measurement of  obesity. An increased BMI is considered 
a significant risk factor for early manifestations of  
neurodegenerative diseases and emotional distress, not only 
for depression or anxiety symptoms but also for a wider 
range of  psychopathologies11. However, some authors have 
suggested that BMI is inferior to alternative measurements 
such as the waist-to-hip ratio (WHR) or waist-to-height ratio 
(WTHR), which are indicators of  central obesity12,13. Others 
have shown that these measurements are highly correlated 
with BMI14. They have a similar strength of  association with 
risk of  cardiovascular disease, although they have a lack of  
standardized measurement protocols, reference data and 
accuracy in severe obesity15.
The aims of  our study were: (a) to explore the presence 
of  OSA in a sample of  severely obese patients seen at a 
Portuguese referral centre for the treatment of  obesity; and (b) 
to evaluate the association of  BMI, OSA and sleep architecture 
with cognitive functioning, emotional distress and comorbid 
diseases. This research is particularly important because: (1) 
it emphasizes the study of  OSA based on a PSG for patients 
with extreme conditions such as severe obesity; (2) it highlights 
the importance of  BMI as a screening tool for OSA; and (3) it 
stresses the association of  BMI and AHI in OSA versus non-
OSA patients, with the cognitive and emotional domains in a 
population less than 65 years of  age (i.e., not yet considered 
elderly)16. Interventions may be more active in this age group. 
Additionally, the BMI constitutes an early and cost-effective 
screening method for patients at high risk of  OSA, particularly 
in primary care settings, since it is in obese people that the 
incidence of  OSA is higher17.
METHODS
Sample
The present study is part of  a project presented to the 
Ethics Committee of  the Centro Hospitalar Universitário de 
Lisboa Norte and was approved on March 2012. After obtaining 
approval from the Ethics Committee, we explored the results 
of  neuropsychological and emotional evaluations of  61 patients 
with severe obesity (BMI≥40kg/m2) out of  an initial number of  
120, who sought treatment at the Morbid Obesity Consultation 
between May 2012 and December 2015, and were invited to 
perform overnight PSG at the Pulmonology Department. PSGs 
were performed with an Alice 5 device (Philips Respironics®, 
USA), included monitoring of  respiratory flow, respiratory 
effort rate, arterial oxygen saturation, electroencephalogram 
and electromyogram of  mentis muscles and were reviewed by 
a Pulmonologist with training in sleep disorders according to 
internationally agreed criteria from American Academy of  Sleep 
Medicine 200718.
We collected data related to sleep parameters like 
AHI, minimal oxygen saturation (MinSO2), mean oxygen 
saturation (MeanSO2), Rapid Eye Movement sleep (REM 
sleep), sleep latency, sleep efficiency, microarousals and non-
REM stages N1, N2, N3, from the individual PSG record of  
nocturnal sleep.
Eligibility criteria for the study assessment were age 
between 18 and 65-years-old, without any known diagnosis of  
psychiatric or neurological disorders, had at least four years of  
schooling, had corrected hearing and vision and unknown OSA.
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Materials
We administered a sociodemographic/clinical questionnaire 
to collect personal characteristics and relevant clinical data. We 
gave patients a pen-paper neuropsychological battery of  evaluation 
comprising Wechsler Intelligence for Adults (WAIS)-III19 [subtest 
of  Digit Span (for attention and working memory), Digit Symbol 
(for fine motor control and learning speed), Search Symbol (for 
processing speed), Vocabulary (for level of  education and acquired 
knowledge)], and Rey-Osterrieth Complex Rey Figure (RCF)20 for 
perceptual/visuospatial ability and memory; Rey Auditory Verbal 
Learning Test (RAVLT)21 for episodic memory, Stroop Colour 
Test22 for resistance to interference; Trail-making Test (TMT)23 for 
cognitive flexibility; Wisconsin Card Sorting Test (WCST)24 for 
problem solving and abstract thinking, and Hopkins Symptom 
Checklist-Revised (SCL-90-R, Portuguese Version)25 for distress 
symptomatology.
The selection of  the neuropsychological battery was in 
line with the impact that obesity has on attention, perception, 
memory, executive functions and emotional performance of  
obese patients11,26-28. We sought to verify the impact of  extreme 
obesity and OSA on cognitive function.
Procedures
At the end of  their required endocrinology 
consultation, patients were invited to participate in the 
study. We adopted a sequential sampling sequence, assuming 
a non-attendance rate of  the first query superior to 30%29. 
We explained the purpose of  the study to each patient, their 
voluntary interest was confirmed and informed consent 
information was obtained.
We took anthropometric measurements such as weight, 
height, neck circumference (NC), waist circumference (WC) and 
hip circumference (HC).
We calculated the BMI as the weight (kg) divided by 
the height squared (m2), the WHT as the WC (cm), divided by 
the HC (cm), and the WHTR as the WC (cm) divided by the 
height (cm).
We collected data from the clinical records of  
patients on vascular risk factors such as HTN, DM, 
dyslipidemia, snoring and cognitive complaints, (attention/
concentration difficulties and poor mental flexibility) and 
we categorized them as a dichotomous variable: “present or 
not present”. We collect information about the number of  
hours of  sleep per night on workdays and excessive daytime 
sleepiness (EDS) measured by the Epworth Sleepiness 
Scale values which scores varied from 0 (minimum) to 24 
(maximum)30.
We considered 4 groups regarding the AHI: <5 
(non-OSA), ≥5 (mild-OSA), between 15-30 (moderate-OSA) 
and ≥30 (severe-OSA)31.
Neuropsychological assessments were carried out 
individually, usually between 2pm and 6pm and prior to the 
performance of  the PSG. They had an average duration of  45 
minutes and was applied by a psychologist with a specialization 
focus in neuropsychology.
Statistical analysis
The initial objective of  the present work was to study 
the executive functioning through the WCST in severe obese 
patients with and without OSA, submitted to conventional 
versus surgical treatment for weight loss. Assuming that the 
WCST has a t-score of  50 and a standard deviation of  10, 
50 patients per group would be needed to compare bariatric 
surgery with the conventional method for an alpha error of  
5% and a power of  70%. Statistical analysis was performed 
using the Statistical Package for the Social Sciences version 
24.0 for Windows software program (IBM Corp., Armonk, 
NY, USA).
Since most of  the variables did not follow a normal 
distribution, we used non-parametric analytic methods: 
Spearman’s correlation test for quantitative measurements, 
Tau_b Kendall’s for correlations between quantitative and 
scaled measurements, Man-Whitney and Kruskal-Wallis tests 
to verify the homogeneity of  distribution of  variables by 
gender, age, qualifications and employment status and Chi-
Square for dummy variables. The significance level was set at 
p<0.05.
RESULTS
Overall sample (n=61)
Sociodemographic and clinic characteristics are 
expressed in Table 1 and the anthropometric measurements as 
well as the difference of  medians for genders are presented in 
Table 2.
The age of  the sample ranged between 20 and 63-years-
old with a mean of  42.61±18 for women and 40.08±12.61 for 
men.
The distribution of  the BMI, AHI and EDS by the 
severity of  OSA together with the characteristics of  the sleep 
parameters are shown in Table 3 and Table 4, respectively. 
Significant differences for the sociodemographic, sleep and 
anthropometric measurements between groups are expressed in 
Table 5.
The unemployed patients revealed a greater BMI (K-
W=10.355, p=.016) than the employed or pensioners patients.
BMI was strongly correlated with NC (r=.405, p=.001), 
WC (r=.327, p=.010), HC (r=.705, p=.000), WHT (r=.293, 
p=.022) and WHTR (r=.789, p=.000).
OSA was presented in 65.6% of  the sample (n=40), 80% 
were women (n=32), 20% men (n=8) with the majority reporting 
to snore (72.5%, n=29) and to have no cognitive complaints 
(67.5%, n=27).
AHI significantly increased with weight (r=.379, p=.003), 
NC (r=.608, p=.000), WC (r=.437, p=.000), BMI (r=.354, 
p=.005), WHR (r=.327, p=.010)   and WHTR (r=.371, p=.003) 
and over age groups (K-W=9.002; p=.029).
HTN was the only diagnosed comorbidity that showed to 
be significantly higher in OSA patients than in non-OSA patients 
(χ2=10.659, p=.014; non- OSA=13,8%; mild-OSA=24.1%; 
moderate-OSA=20.7%; and severe- OSA=41.4%).
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Table 1. Sociodemographic and clinical characterization of  the sample 
(n=61).
n %
Gender
Female 49 80.3
Male 12 19.7
Age
20-30 years 12 19.7
31-40 years 18 29.5
41-50 years 11 18.0
> 50 years 20 32.8
Marital status
Singles 8 13.1
Married/unmarried couples 43 70.5
Separate/divorced 10 16.4
Employment Status
Employed 31 50.8
Unemployed 22 36.1
Pensioners 6 9.8
Others 2 3.3
Qualifications
1º Cycle of  basic school 10 16.4
2º Cycle of  basic school 9 14.8
3º Cycle of  basic school 19 31.1
Secondary school 19 31.1
Bachelor/graduation/master 4 6.6
Income
Without Income 5 8.2
< 500 euros 24 39.3
500-750 euros 18 29.5
750-1000 euros 7 11.5
1000-1500 euros 5 8.2
> 1500 euros 2 3.3
Clinical diagnosis
Arterial hypertension 29 47.5
Type 2 diabetes 11 18.0
Dyslipidemia 6 9.8
Life habits
Tobacco consumption 11 18.0
Alcoholic beverages consumption 8 13.1
Regular physical activity 13 21.3
Overweight since childhood 26 42.6
Complaints
Cognitive complaints 20 32.8
Snoring 42 68.9
OSA Diagnosis
Non-OSA 21 34.4
Mild-OSA 12 19.7
Moderate-OSA 10 16.4
Severe-OSA 18 29.5
Non-OSA versus OSA patients
The mean age of  the non-OSA patients (n=21; 
µ=36.10±12.165) was lower than the mean age of  the OSA 
patients (n=40; µ=45.28±9.743) and significantly different for 
the non-OSA group and the severe OSA group (U=-2.817; 
p=.006). HTN was considerably present in the OSA patients 
(χ2=10.659, p=.014; non-OSA with HTN=13.8% versus OSA 
with AHT=86.2%). 
BMI was highly associated with the AHI when we 
compared the non-OSA group and the group including all the 
patients with OSA (r=.354, p=.005).
Significant associations between the BMI, AHI and 
cognitive, emotional and comorbid variables are presented in 
Table 6.
Cognitive complaints for the non-OSA patients were 
associated with obsessive-compulsive symptoms (r=.432, 
p=.023), interpersonal sensitivity (r=.468, p=.014), phobic 
anxiety (r=.462, p=.019) and psychoticism (r=.482, p=.013).
Cognitive complaints for the OSA patients were 
considerable associated to symptom distress index (r=.308, 
p=.020), somatization (r=.314, p=.019), interpersonal sensitivity 
(r=.277, p=.040), depression (r=.373, p=.005), anxiety (r=.276, 
p=.041), phobic anxiety (r=.294, p=.033) and psychoticism 
(r=.275, p=.045).
DISCUSSION
More than half  of  our sample was revealed to have OSA 
and an excess of  generalized and central adiposity, reflected by 
anthropometric measurements that were significantly above 
those established for severe obesity. The women were slightly 
older than the men, who presented the highest weights greatest 
neck and waist circumferences and greatest local adiposity. The 
high neck and waist circumferences and severest OSA in men 
support the need for routine sleep investigation in obese people 
because the pattern of  fat distribution and ageing is described as 
related to increased morbidity and mortality, generally associated 
with OSA32.
EDS is considered a clinically important symptom of  
OSA; this value was well above the average value of  4.6 of  the 
general population33. Nevertheless, it was not related to the AHI 
and did not appear as a cardinal symptom. Similarly, a recent 
Portuguese study performed in a sleep clinic evaluated the 
perception of  sleepiness before OSA treatment. The perception 
of  EDS prior to treatment significantly increased after treatment 
because it was underestimated by the patients30. Kapur et al.34 
also found no association between EDS and the AHI in a cohort 
study of  6,440 subjects. Specialists have argued the necessity 
for specific tools to evaluate the risk of  OSA because screening 
questionnaires such as the Epworth Sleepiness Scale have very 
weak sensitivity and are not good predictors of  the disorder35. 
The absence of  variation between the OSA groups in the 
number of  hours slept per night may have contributed to the 
lack of  variation in the EDS. Collecting data from a population 
with a normal BMI for comparison could be useful to further 
investigate this finding.
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Table 2. Descriptive statistics of  the anthropometric measurements of  the total sample and differences of  medians for genders performed by Man-Whitney test.
*p<0.05; **p<0.01; SD = Standard deviation.
Total sample
(n=61)
Mean±SD
Men
(n=12)
Mean±SD
Women
(n=49)
Mean±SD
Differences of
medians
(p value)
Weight (Kg) 123.50±17.74 137.50±16.20 120.07±16.50 .004**
Height (cm) 162.52±9.41 172.66±11.89 160.04±6.81 .001**
Neck circumference (cm) 42.73±5.02 46.45±46.00 41.81±41.00 .000**
Waist circumference (cm) 128.04±14.37 138.75±13.23 125.42±13.50 .004**
Hip circumference (cm) 137±10.17 133.58±10.14 137.83±10.11 .211
Body mass index (Kg/m2) 46.71±5.95 46.18±4.01 46.84±6.36 .863
Waist-to-hip ratio (cm) 0.93± 10 1.04±.11 .91±.081 .000**
Waist-to-height ratio (cm) .78±.09 .80±.091 .78±.095 .261
Table 3. Descriptive statistics of  body mass index, apnea hypopnoea index and Epworth Sleepiness Scale between OSA groups.
SD=standard deviation.
Measurements
Severity of  Apnoea/Hypopnoea Syndrome
Non-OSA patients Mild OSA patients Moderate OSA patients Severe OSA patients
(n = 21) (n=12) (n=10) (n=18)
Mean±SD Mean±SD Mean±SD Mean±SD
Body mass index (Kg/m2) 44.06±3.00 48.77±8.13 45.99±5.86 48.82±6.07
Apnoea/hypopnoea Index/hour 1.45±1.48 9.61±3.08 21.24±2.94 58.53±25.63
Epworth Sleepiness Scale (EDS) 5.05±3.73 6.00±4.20 7.90±3.72 7.22±5.07
Table 4. Descriptive statistics of  sleep parameters of  the total sample and Non-OSA and OSA patients.
SD=standard deviation.
Sleep parameters
Total sample Non-OSA patients OSA patients
(n=61) (n=21) (n=40)
Mean±SD Mean±SD Mean±SD
Apnoea/hypopnoea index (frequency/hour) 23.14±27.70 1.45±1.48 34.53±28.16
Mean oxygen saturation (%) 94.26±1.99 95.38±1.284 93.68±2.06
Minimal oxygen saturation (%) 81.60±9.40 88.33±6.11 81.60±9.40
REM sleep latency (minutes) 151.76±94.20 169.03±89.22 151.76±94.20
REM sleep (%) 12.56±6.07 13.41±6.47 12.12±5.88
Sleep efficiency (%) 80.08±13.69 82.59±11.47 78.76±14.69
Non-Rem N1 stage (%) 17.80±21.07 15.93±19.79 18.78±21.90
Non-Rem N2 stage (%) 65.69±9.94 66.04±8.69 65.50±10.64
Non-Rem N3 stage (%) 13.63±13.86 12.55±8.35 14.20±6.09
Arousal index (frequency/hour) 32.78±24.67 20.28±11.42 39.34±27.22
Excessive daytime sleepiness 6.34±4.301 5.05±3.735 7.03±4.463
Number hours slept by night 7.163±1.104 7.245±.952 7.120±1.186
The BMI was strongly related to oxygen desaturation 
and DM in OSA patients. Previous studies have shown that 
long-term protracted intermittent hypoxia can result in sleep 
fragmentation, cerebral vascular deficits, cognitive impairments 
and neurodegeneration, possibly due to cumulative effects36. 
This exposure leads to altered insulin resistance and glucose 
disposal, impacting the incidence of  DM, which should motivate 
the early identification and intervention of  OSA37. Intermittent 
hypoxemia has also been proposed to influence mood among 
OSA patients and suggests the need for interventions focused 
on the enhancement of  adaptive coping strategies, particularly 
for dealing with depressive symptoms38. These interventions 
may help to optimize the standard treatment of  OSA patients 
and could contribute to reducing psychological distress39. 
Our investigation highlights the association between the 
BMI and the global severity index of  distress symptomatology 
and phobic anxiety in OSA patients. An important aspect seems 
to be the general dimension of  symptoms of  maladjustment 
that also encompass social anxiety and agoraphobic symptoms, 
with consequent decreases in social contact, social activities and 
occupational activities, reinforcing weight gain and possibly 
OSA40. The patient symptoms revealed that significant emotional 
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Table 5. Significant differences for the sociodemographic, sleep and anthropometric measurements between groups.
*p<0.05; **p< 0.01; Group 1: non-OSA; Group 2: mild-OSA; Group 3: moderate-OSA; Group 4: severe-OSA.
Variables
Groups comparisons (Man-Whitney Z and p value)
1 and 2 1 and 3 1 and 4 2 and 3 2 and 4 3 and 4
Age
-.2.817
.006*
Apnea/Hypopnea Index
-4.721 -4.42 -5.328
.000** .000** .000**
Mean Oxygen Saturation
-3.540
.000**
Minimal Oxygen Saturation
-2.774 -2.858 -4.119
.005**  .003** .000**
Microarousals
-3.945
.000**
REM sleep latency
-2.282 -2.117 -2.493
.022* .034* .013*
Weight
-2.635
.007**
Neck circumference
-4.409 -2.702 -3.489
.000** .006** .000**
Waist circumference
-2.963
.003**
Body Mass Index
-2.564
.010*
Waist-to-hip ratio
-2.014
.043*
Waist-to-height ratio
-2.578
.010*
Table 6. Significant nonparametric correlations (Tau_b Kendall and Spearman) between body mass index and apnoea/hypopnoea Index and sociodemo-
graphic, cognitive, emotional, sleep and comorbid variables for Non-OSA patients (n=21) and OSA patients (n=40).
*p< 0.05; **p<0.01.
Non-OSA patients OSA patients
(n=21) (n=40)
Variables Items BMI AHI BMI AHI
Sociodemographic characteristics
Gender .411* .430**
Income -.449* .268*
Sleep measurements
Mean Oxygen Saturation -.483**
Minimal Oxygen Saturation -.525**
Cognitive measurements
Deferred Recognition -.354*
Stroop Interference -.392* .383*
Rey Complex Figure (Copy) -.317*
WCST administered trails .404**
WCST % errors .315*
WCST % perseverative responses .318*
WCST % concept. level responses -.329*
WCST nr. completed categories -.423**
WCST failure to maintain set .315*
WCST learning to learn -.554**
Emotional measurements
Global Severity Index .318*
Phobic anxiety .416**
Comorbidities Diabetes .389**
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discomfort is associated not only with OSA but also with the 
degree of  obesity. The symptoms may be linked to the lower 
activity levels and increased passive coping strategies reported 
by OSA patients, but these are also referred to by severely obese 
patients41.
Our investigation also stressed that in addition to the 
presence of  emotional symptomatology, the increased BMI was 
linked to a decrease in the core abilities of  executive functioning 
in OSA patients, which has also been described in the obese 
population42. Results of  the Stroop test interference, WCST 
and RCF in OSA patients emphasize the reduction of  inhibitory 
control, cognitive flexibility, problem solving, planning and 
perceptual/sensorial understanding of  the environment, 
suggesting a dysfunctional executive profile. Inhibitory control 
refers to the general ability to withhold or inhibit inappropriate 
behaviour and its decline has been implicated in a range of  
impulsive psychiatric disorders that have high comorbidity, 
along with maladaptive eating behaviours and obesity. Inefficient 
inhibitory control is related to the inability to maintain 
consistent directed attention over time and may therefore play 
a role in the development and/or maintenance of  obesity43. 
Visuoperceptive and cognitive flexibility difficulties suggest 
a decline in the ability to organize, plan and solve problems, 
which can result in additional problems with generating 
alternative behaviour patterns when presented with ambiguous 
information and adjusting behaviour when the rules change, 
namely, in dealing with food cues. Reduced executive functioning 
has been systematically reported and may represent a barrier 
to adherence to new nutritional guidelines and a tendency to 
continue the previous regime, perpetuating weight gain, obesity 
and possibly OSA44. Enhancing the information offered by 
healthcare providers and traditional sources, furnishing lifestyle 
change interventions, empowering patient with adequate eating 
habits, provide cognitive therapy behavioral, support groups 
and cognitive training are all important for a complementary 
approach to the patient45. These tools, however, should not 
delay the provision of  bariatric surgery, the gold standard 
treatment for severe obesity and a valuable treatment option for 
OSA, regardless of  the specific type32,46.
In contrast, the AHI is not associated with the 
interference of  Stroop performance but rather with difficulties 
in episodic memory, especially in deferred recognition, which 
may indicate the failure to use adequate strategies to manipulate 
and organize verbal information. Alterations in hippocampal 
structures have been reported in patients with OSA. This 
cerebral structure is extremely sensitive to hypoxic damage, and 
its atrophy is associated with memory impairments47. A reduced 
recognition may be responsible for the increased difficulties 
in maintaining sets on the WCST, rather than a disturbance in 
selective attention, which could also influence the interference 
task. Increased difficulties in response maintenance may lead 
these patients to higher vulnerability situations, such as when 
trying to sustain a consistent adherence to the CPAP treatment.
Concerning the architecture of  sleep, most patients 
with OSA present the severest impairments. These patients 
typically show sleep latency greater than 30 minutes, a severe 
microarousal index over 10, sleep efficiency less than 85% 
and a mean MinSO2 of  less than 85%, indicating desaturation 
of  oxyhemoglobin, which is associated with significant sleep 
fragmentation and inefficiency. These characteristics are similar 
to the findings from an Australian sample and are consistent 
with pathophysiological mechanisms linking OSA to DM and 
a decline in oxygen saturation48. The current study shows the 
importance of  measurements such as BMI as markers for the 
diagnosis of  DM in OSA patients, a relationship that was very 
clear in our sample.
Notably, most of  the patients mentioned that the onset 
of  obesity was in childhood. Previous reports have found that 
the higher prevalence of  OSA is not confined to adults, with 
obese children recently showing a 46% prevalence of  OSA 
compared to 33% of  children seen in a general paediatric clinic1. 
This may indicate the importance of  a prompt diagnosis of  
OSA and the prevention of  early obesity owing to their ability to 
increase the risk for pathologies such as DM, HTN, dyslipidemia, 
or neurocognitive impairment.
HTN was significantly increased with the severity of  
OSA, indicating a clear relationship. We hypothesized that a 
larger sample size would emphasize other comorbidities that are 
associated with OSA, such as dyslipidemia.
We concluded that BMI was far above average in the 
sample, representing a valuable marker for ‘health risk’49. The 
BMI increased with the severity of  OSA, although it showed 
no significant relationship with AHI. Moderate OSA was more 
strongly associated with lower BMI than mild OSA was, meaning 
that moderate OSA may be worse but less symptomatic, which 
requires further study.
Limitations regarding the representativeness of  
the studied population include our small sample size, 
the disproportion of  men and women, and the absence 
of  a healthy control group. The sample size may explain 
the association of  the BMI and neuropsychological 
performance only with the OSA patients. We conjectured 
that with a large sample this association would include also 
the non-OSA patients. However, it is important to refer that 
our predominantly female sample is similar to the typical 
candidates for treatment of  severe obesity in Portugal, and 
we compared patients with and without OSA50. A strength 
of  this study is that PSG was used as the standard test for 
diagnosing OSA. This methodology reinforced that the 
higher the BMI, the greater the severity of  OSA; therefore, 
BMI is particularly relevant to this sleep disorder. Because of  
their significance, the results should be further investigated 
with a large number of  patients and after CPAP treatment.
In summary, we have shown that OSA is significantly 
present in severely obese patients. BMI is well correlated with 
cognitive measurements, sleep, emotional parameters and 
comorbidities in OSA patients. The BMI is objective, cheap and 
easy to obtain. It can be an important first step and a good start 
in identifying asymptomatic patients to categorize populations 
at high risk of  OSA, especially in primary care settings.
8Ribeiro OR, et al
Sleep Sci. 2020; Ahead of  Print
Particular attention must be given to distress 
symptomatology. This seems to be associated with cognitive 
complaints in OSA and non-OSA patients, suggesting a need for 
psychological interventions focused on adaptive coping strategies 
that deal with depressive symptoms. Neuropsychological 
screening may provide information about cognitive impairment, 
mostly associated with executive functioning, which may 
constitute a barrier to the adherence to treatment guidelines, 
perpetuating obesity and OSA.
These findings may offer additional insight into the 
management of  obese patients outside of  sleep units who 
require follow-up, because these units are highly specialized and 
have long patient waitlists and scarce human resources.
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